Shilpa J. Desai

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Jeffrey S. Heier, Saleema Kherani, Shilpa J. Desai et al. · The Lancet · 2017 · 220 citations

Open-label Trial, Translational Medicine, Ocular Disease +8

Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)

Robert B. Bhisitkul, Shilpa J. Desai, David S. Boyer et al. · Ophthalmology · 2016 · 88 citations

Ocular Disease, Ophthalmology, Ranibizumab-treated Amd Subjects +6

Practice Patterns and Outcomes of Intravitreal Anti-VEGF Injection for Retinopathy of Prematurity

Nimesh A. Patel, Luis Acaba-Berrocal, Sandra Hoyek et al. · Ophthalmology · 2022 · 23 citations

Ocular Disease, Vitreous Body, Ophthalmology +7

Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity

Nimesh A. Patel, Luis Acaba-Berrocal, Sandra Hoyek et al. · Ophthalmology · 2022 · 22 citations · Full text

Ocular Disease, Vitreous Body, Ophthalmology +4

PARACENTRAL ACUTE MIDDLE MACULOPATHY IN PREGNANCY

Xuejing Chen, Shilpa J. Desai, Caroline R. Baumal · Retinal Cases & Brief Reports · 2017 · 18 citations